ANZCA’s statement on desflurane supports the continued education and actions to reduce usage.

The national shortage of IV fluid bags across multiple suppliers in Australia is ongoing and anticipated to continue until March 2025.

Generous donation expands the CTN pilot grant scheme

POM health care projects have been recognised in the 2024 Victorian Public Healthcare Awards.  

Does your department or hospital have an audit plan proforma that you could share with the Scholar Role Sub-committee?

The SRSC has reviewed the requirements for regional and greater meeting attendance.

The college today received an update from the Medical Board of Australia on the expedited specialist pathway.

New this month: Safety alert – Unfamiliar drug presentations and concentrations; webAIRS 2025

ANZCA, along with peak diabetes, obesity and gastroenterological bodies, has produced clinical practice recommendations for patients using GLP-1/GIP receptor agonists.

This is a report following the FPM Board meeting held at ANZCA House on 8 December 2024.